Applied Clinical Trials
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
July 1 · 1 min · 1.5 MB
0:00-1:32
Streams straight from the publisher. podnod never proxies or re-hosts episode audio.
In today's ACT Brief, we examine a major trial retraction and regulatory action against a rare disease drug, regulatory scenarios for selective safety data collection, and FDA's domestic manufacturing incentive program.
No links were found in this episode’s notes.